How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease

by Andrew Ramadeen, Paul Dorian
Published 2012-01-01

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia

by Hugo Van Herendael, Paul Dorian
Published 2010-06-01

A Comparison of Two Nights of Ambulatory Sleep Testing in Arrhythmia Patients

by Asmaa M. Abumuamar, Paul Dorian, David Newman, Colin M. Shapiro
Published 2018-01-01

Developing a Pan-Canadian Registry of Sudden Cardiac Arrest: Challenges and Opportunities

by Katherine Allan, PhD, Paul Dorian, MD, MSc, FRCPC, Steve Lin, MD, MSc, FRCPC
Published 2019-03-01

DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study protocol for a randomized controlled trial

by Ian R. Drennan, Paul Dorian, Shelley McLeod, Ruxandra Pinto, Damon C. Scales, Linda Turner, Michael Feldman, P. Richard Verbeek, Laurie J. Morrison, Sheldon Cheskes
Published 2020-11-01

Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes

by Cameron H. Landry, MD, MSc, Meena Fatah, BSc, Kim A. Connelly, MBBS, PhD, Paul Angaran, MD, MSc, Robert M. Hamilton, MD, MHSc, Paul Dorian, MD, MSc
Published 2021-04-01

Detecting Patients With Nonvalvular Atrial Fibrillation and Atrial Flutter in the Canadian Primary Care Sentinel Surveillance Network: First Steps

by John A. Queenan, PhD, Behrouz Ehsani-Moghaddam, PhD, Stephen B. Wilton, MD, MSc, Paul Dorian, MD, MSc, Jafna L. Cox, MD, Allan Skanes, MD, David Barber, MD, Roopinder K. Sandhu, MD, MPH
Published 2021-03-01

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

by Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha
Published 2020-09-01

Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysisStrengths an...

by Katherine S. Allan, MASc, PhD, Theresa Aves, MSc, Shaunattonie Henry, RN, MN, MAEd, CIC, Laura Banfield, MSc, J. Charles Victor, MSc, Paul Dorian, MSc, MD, Jeff S. Healey, MD, Jason G. Andrade, MD, Sandra L. Carroll, RN, PhD, Michael H. McGillion, RN, PhD
Published 2020-07-01

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction

by Laura Jimenez-Juan, MD, Gauri R. Karur, MD, Kim A. Connelly, MD, PhD, Djeven Deva, MD, Raymond T. Yan, MD, Rachel M. Wald, MD, Sheldon Singh, MD, General Leung, PhD, Anastasia Oikonomou, MD, PhD, Paul Dorian, MD, Paul Angaran, MD, Andrew T. Yan, MD
Published 2017-04-01

Multi-centre implementation of an Educational program to improve the Cardiac Arrest diagnostic accuracy of ambulance Telecommunicators and survival outcomes for sudden cardiac arre...

by Christian Vaillancourt, Manya Charette, Sarika Naidoo, Monica Taljaard, Matthew Church, Stephanie Hodges, Shannon Leduc, Jim Christenson, Sheldon Cheskes, Katie Dainty, Michael Feldman, Judah Goldstein, John Tallon, Jennie Helmer, Aaron Sibley, Matthew Spidel, Ian Blanchard, Jim Garland, Kathryn Cyr, Jamie Brehaut, Paul Dorian, Colette Lacroix, Sandra Zambon, Venkatesh Thiruganasambandamoorthy
Published 2021-03-01

Flecainide and elevated liver enzymes in α1-antitrypsin deficiency

by David J.A. Jenkins, MD, PhD, FRCP, Michael Freeman, MD, FRCPC, Iqwal Mangat, MD, FRCPC, Koruba Srichaikul, MD, MSc, Viranda H. Jayalath, MSc, Dorothea Faulkner, RD, PhD, John L. Sievenpiper, MD, PhD, FRCPC, Cyril W.C. Kendall, PhD, Alexander Romaschin, PhD, Young-In Kim, MD, FRCPC, Paul Dorian, MD, FRCPC, FHRS
Published 2016-05-01

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

by Christian Torp Pedersen, G. Neal Kay, Jonathan Kalman, Martin Borggrefe, Paolo Della-Bella, Timm Dickfeld, Paul Dorian, Heikki Huikuri, Youg-Hoon Kim, Bradley Knight, Francis Marchlinski, David Ross, Frédéric Sacher, John Sapp, Kalyanam Shivkumar, Kyoko Soejima, Hiroshi Tada, Mark E. Alexander, John K. Triedman, Takumi Yamada, Paulus Kirchhof, Gregory Y.H. Lip, Karl Heinz Kuck, Lluís Mont, David Haines, Jukia Indik, John Dimarco, Derek Exner, Yoshito Iesaka, Irene Savelieva
Published 2014-10-01

Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in Canada

by Dennis T. Ko, MD, MSc, Tareq Ahmed, MPH, Peter C. Austin, PhD, Warren J. Cantor, MD, Paul Dorian, MD, Michael Goldfarb, MD, MSc, Yanyan Gong, MSc, Michelle M. Graham, MD, Jing Gu, MD, PhD, Nathaniel M. Hawkins, MD, MPH, MBChB, Thao Huynh, MD, PhD, Karin H. Humphries, MBA, DSc, Maria Koh, MSc, Yoan Lamarche, MD, MSc, Laurie J. Lambert, PhD, Patrick R. Lawler, MD, MPH, Jean-Francois Légaré, MD, Hung Q. Ly, MD, Feng Qiu, MSc, Ata ur Rehman Quraishi, MBBS, Derek Y. So, MD, MSc, Robert C. Welsh, MD, Harindra C. Wijeysundera, MD, PhD, Graham Wong, MD, MPH, Andrew T. Yan, MD, FRCPC, Yana Gurevich, MD, MPH
Published 2021-08-01